文献速递临床试验与 GCP

右美托咪定对清醒开颅术患者术后谵妄影响的随机对照试验研究方案

Effect of dexmedetomidine on postoperative delirium in patients undergoing awake craniotomies: study protocol of a randomized controlled trial.
PubMed 文献 · Trials · 2023-09-25

本研究为前瞻性、单中心、双盲、平行组随机对照试验,拟纳入择期清醒开颅术患者,随机分为右美托咪定组与对照组。右美托咪定组在导尿前10分钟起以0.2 µg/kg/h持续输注至硬脑膜关闭结束,对照组给予等量生理盐水。主要结局为术后连续5天采用意识模糊评估法测定的术后谵妄累积发生率和严重程度。

要点

  • 研究旨在探讨右美托咪定能否预防清醒开颅术患者的术后谵妄。
  • 右美托咪定组于导尿前10分钟起以0.2 µg/kg/h输注至硬脑膜关闭结束。
  • 主要结局为术后连续5天用意识模糊评估法测定的谵妄累积发生率与严重程度。

核心结论

  • 本研究旨在探讨右美托咪定能否预防清醒开颅术患者的术后谵妄,并将为术中干预对清醒开颅术患者术后谵妄预防的影响提供循证临床实践证据。

研究设计与样本

  • 前瞻性、单中心、双盲、平行组随机对照试验,纳入择期清醒开颅术患者,随机分为右美托咪定组和对照组。
  • 右美托咪定组在导尿前10分钟起以0.2 µg/kg/h持续输注至硬脑膜关闭结束。
  • 对照组在相同设置下给予等量生理盐水。

主要发现

  • 主要结局为术后连续5天采用意识模糊评估法测定的术后谵妄累积发生率和严重程度。
  • 次要结局包括术中知晓质量、神经系统检查刺激强度、疼痛严重程度、恢复与睡眠质量及安全性结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Postoperative delirium (POD) is a common complication, and it has a high incidence in neurosurgery patients. Awake craniotomy (AC) has been widely performed in patients with glioma in eloquent and motor areas. Most of the surgical procedure is frontotemporal craniotomy, and the operation duration has been getting longer. Patients undergoing AC are high-risk populations for POD. Dexmedetomidine (Dex) administration perioperatively might help to reduce the incidence of POD. The purpose of this study is to investigate the effect of Dex on POD in patients undergoing AC. METHODS: The study is a prospective, single-center, double-blinded, paralleled-group, randomized controlled trial. Patients undergoing elective AC will be randomly assigned to the Dex group and the control group. Ten minutes before urethral catheterization, patients in the Dex group will be administered with a continuous infusion at a rate of 0.2 µg/kg/h until the end of dural closure. In the control group, patients will receive an identical volume of normal saline in the same setting. The primary outcome will be the cumulative incidence and severity of POD. It will be performed by using the confusion assessment method in the first 5 consecutive days after surgery. Secondary outcomes include quality of intraoperative awareness, stimulus intensity of neurological examination, pain severity, quality of recovery and sleep, and safety outcomes. DISCUSSION: This study is to investigate whether the application of Dex could prevent POD in patients after undergoing AC and will provide strong evidence-based clinical practice on the impact of intraoperative interventions on preventing POD in AC patients. TRIAL REGISTRATION: ClinicalTrials.gov, NCT05195034. Registered on January 18, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Li M, Liu M, Cui Q, et al. Effect of dexmedetomidine on postoperative delirium in patients undergoing awake craniotomies: study protocol of a randomized controlled trial. Trials. 2023. PMID: 37743486. doi:10.1186/s13063-023-07632-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。